A

Advanced Biomed Inc
NASDAQ:ADVB

Watchlist Manager
Advanced Biomed Inc
NASDAQ:ADVB
Watchlist
Price: 0.3011 USD -2.59% Market Closed
Market Cap: $6.5m

Net Margin

0%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Net
Margin
US
Advanced Biomed Inc
NASDAQ:ADVB
6.5m USD
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.4B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.1B AUD
Loading...
CN
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
42.8B CNY
Loading...
SE
Medicover AB
STO:MCOV B
31.2B SEK
Loading...
US
Veracyte Inc
NASDAQ:VCYT
3.1B USD
Loading...
DE
Synlab AG
XETRA:SYAB
2.4B EUR
Loading...
IN
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
230.2B INR
Loading...
CN
Dian Diagnostics Group Co Ltd
SZSE:300244
16.2B CNY
Loading...
CN
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
15.3B CNY
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Advanced Biomed Inc
Glance View

Market Cap
6.5m USD
Industry
N/A

Advanced Biomed Inc is a US-based company operating in industry. The company is headquartered in Reno, Nevada and currently employs 40 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.

ADVB Intrinsic Value
0.1343 USD
Overvaluation 55%
Intrinsic Value
Price
A
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Back to Top